Content about United States

October 18, 2010

Prestige makeup in U.S. department stores is on the rise, marking the first time in...

October 17, 2010

Supervalu on Monday announced its acquisition of six Rinderer’s Drug Stores here, three of which...

October 17, 2010

The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market...

JERUSALEM The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market a generic version of a drug designed to treat peptic ulcers.

The generic drug maker said that its drug, lansoprazole, is a generic version of Takeda’s Prevacid SoluTab. Annual sales of the branded product were approximately $453 million in the United States, according to IMS sales data.

Sandoz, the generics division of Swiss drug maker Novartis, also announced the launch of its own version of Prevacid SoluTab.

October 17, 2010

Winn-Dixie on Monday announced its What-A-Deal flu prevention program....

October 14, 2010

Under a settlement reached with the Drug Enforcement Administration and the U.S. Attorneys' Offices for...

October 14, 2010

Giant Eagle on Thursday announced the opening of its first Ohio Market District food store...

October 10, 2010

The opening weekend of Tinker Air Force Base’s new Exchange concept—rebranded from the Army and...

October 10, 2010

Humanity has come a long way since the days when people thought sickness came from...

October 10, 2010

Whether it is through the elimination of harsh chemicals, the use of eco-friendly packaging or...

October 10, 2010

Liquid-Plumr has launched a specially formulated clog remover that eliminates the toughest clogs in seven...

October 10, 2010

Johnson & Johnson is set to buy the remaining portion of Dutch biotech company Crucell...

October 10, 2010

Just days after state health officials reported that California is on pace for the worst...

October 7, 2010

The theme of CVS Caremark’s 2010 analyst meeting held Friday morning here in New York...

October 7, 2010

CVS Caremark has no doubt been a trailblazer in the healthcare arena, positioning itself along...

NEW YORK CVS Caremark has no doubt been a trailblazer in the healthcare arena, positioning itself along the front lines to leverage its various points of care to improve outcomes and lower healthcare costs. But with all that CVS Caremark has done and will continue to do in the healthcare space -- and it is no doubt a lot -- it still has more than 7,000 retail locations, and the front of the store continues to be a critical part of its business and a major growth driver for the company.

October 7, 2010

A new study published in the Journal of Epidemiology and Community Health found that the...

NEW YORK A new study published in the Journal of Epidemiology and Community Health found that the nation's average larger waist circumference is an indicator as to why the diabetes rate in America is higher than the rate in England.

James Smith, corporate chair of economics at the nonprofit organization RAND Corp., and researchers found that American men's waists were an average of 3 cm (1.5 in.) larger than those of men in England. Similarly, American women's waists were an average of 5 cm (2 in.) larger than those of women in England.

October 7, 2010

A lightbulb that stays illuminated for three hours without electricity has arrived in the United...

DALLAS A lightbulb that stays illuminated for three hours without electricity has arrived in the United States.

 

MagicBulb, developed in Norway by LED Electronics, is boasted as being the world's first and only rechargeable light bulb.

 

 

October 7, 2010

A new women's health, whole soy germ-based nutritional supplement containing natural S-equol reduced the frequency...

October 6, 2010

CVS Caremark has appointed Jonathan Roberts as COO of its pharmacy benefit management business. He...

October 5, 2010

The National Community Pharmacists Association is urging the Centers for Medicare and Medicaid Services to...

ALEXANDRIA, Va. The National Community Pharmacists Association is urging the Centers for Medicare and Medicaid Services to follow guidance that Congress included in the healthcare-reform law in its implementation of a new Medicaid generic drug reimbursement formula based on average manufacturer price, the organization said Tuesday.

CMS recently withdrew provisions that would have dramatically cut Medicaid pharmacy reimbursement to community pharmacies from a previously proposed AMP rule due to an injunction that the NCPA obtained in 2007.

 

October 4, 2010

The drug market for ulcerative colitis treatments will see modest growth through 2019, according to...

BURLINGTON, Mass. The drug market for ulcerative colitis treatments will see modest growth through 2019, according to a new report by Decision Resources.

The research and advisory firm said that the UC drug market will see growth of $800 million, driven by the uptake of Abbott and Eisai's Humira, Centocor Ortho Biotech/Merck/Mitsubishi Tanabe Pharma/Janssen's Simponi and Millennium's vedolizumab in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

October 3, 2010

Take Care Health Systems, which is owned by Walgreens, announced on Monday that treatment of...

CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, announced on Monday that treatment of pharyngitis and upper respiratory infections at its clinics exceed national quality benchmarks, according to an analysis of data collected through its EMR system by the Jefferson School of Population Health.

September 30, 2010

Due to the nation’s deep recession, states experienced rapid growth in their Medicaid enrollment and...

WASHINGTON Due to the nation’s deep recession, states experienced rapid growth in their Medicaid enrollment and spending last year and expect additional growth, though at a slower pace, in fiscal year 2011, according to a survey of state Medicaid officials in all 50 states released Thursday by the Kaiser Family Foundation’s Commission on Medicaid and the Uninsured.

 

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

BURLINGTON, Mass. The drug market for Crohn's disease treatments will see moderate growth over the next decade, Decision Resources reported Wednesday.

The research firm projected that the market will increase a little more than 31%, from $3.2 billion in 2009 to $4.2 billion in 2019, in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Decision Resources said the the modest growth rate masks such market changes as new and emerging biologics, as well as generic competition.

September 28, 2010

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...